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Caenorhabditis elegans is a well-studied model species of nematode worm that 
has been widely used for anthelmintic (anti-nematode) drug development as drug 
resistance has increased. The nematode Panagrellus redivivus presents itself as an 
alternative nematode to C. elegans that is easy to rear, making it useful for research in 
low-resource settings. In collaboration with the Gabon-Oregon Center, our laboratory 
aims to develop a P. redivivus screening system for natural products. 
Electropharyngeogram (EPG) recordings are similar to electrocardiograms of the 
human heart. In nematodes, EPG recordings show the electrical signals produced by 
rhythmic contractions of the pharynx. Pharyngeal contractions are used as a readout for 
electrical activity of neurons and muscles in nematodes. C. elegans is a hermaphroditic 
species, but P. redivivus is a gonochoristic species with males and females. My study 
tested the hypothesis that adult male and female P. redivivus have different sensitivity 
to anthelmintic drugs. I used EPG recordings to test this hypothesis, while applying 
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ivermectin, an anthelmintic drug. Dimethyl Sulfoxide (DMSO) was the ivermectin 
solvent, and was used as a control. EPG recordings from male and female P. redivivus 
were analyzed using IGOR Pro software. My results suggest that there is no sex 
difference in the sensitivity of P. redivivus to ivermectin, supporting the idea that mixed 
cultures containing both sexes can be used for drug screening experiments.  
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Introduction 
Nematodes make up a diverse class of organisms in the animal kingdom. 
Nematodes as a phylum are over 500 million years old and have adapted to survive with 
a variety of life styles 1. Nematoda has substantial genetic diversity, with 30% - 50% 
expressed sequences from 30 different species found to be unique to those species 2. 
Most nematodes are not parasitic1, but as a result of the diversity of this phylum, the 
parasitic species have broad impact on living things. 
Parasitic worms affect humans, livestock, plants and pets3. The effects of 
parasites can be subtle compared to many other diseases. Parasite infections result in 
lower productivity from livestock and plants, as breeds of animals with higher 
productivity may not be able to survive in a region with high rates of parasitic disease 4. 
Humans may also be forced to leave locations where parasitic diseases persist5. In many 
ways, the cost of parasitic disease can be seen as a loss of potential from animals, plant 
and human beings 4.  
Parasitic worms are also referred to as helminths. Three soil-transmitted 
helminth infections are among the neglected tropical diseases caused by helminths5. 
These diseases are: Ascariasis, Trichuriasis, Lymphatic Filariasis, Schistosomiasis, 
Hookworm infection, and Onchocerciasis (river blindness) 5. Onchocerciasis can cause 
blindness, Lymphatic Filariasis causes elephantiasis and hookworm infections and 
schistosomiasis can cause anemia 5. Persistent soil-transmitted helminth infections in 
childhood are linked to a decrease in school performance, and stunted growth 6. 
Parasitic worm infections and their combined impact on agriculture and human health 
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contribute to poverty. Treatment of these diseases can cause a substantial decrease in 
poverty 5. 
Unfortunately, the reason that soil transmitted helminth infections fall under the 
category of neglected tropical diseases is because nations most impacted by these 
diseases do not have sufficient resources to invest in treatment or drug development to 
the extent needed 3. Endemic helminth infections have been combated with help from 
organizations such as the World Health Organization and the World Bank in West 
Africa 7 or the Pacific Programme to Eliminate Lymphatic Filariasis (PacELF) in the 
Pacific8. Successful campaigns against helminth infections have been conducted in 
tandem with affected communities. Using local health professionals and staff for dosing 
and drug distribution of ivermectin, Onchocerciasis was almost completely eliminated 
in 10 West African countries 7. Collaboration between local health services, 
communities and Japanese research and development of diethylcarbamazine 
hydrochloride (DEC) led to the eradication of Lymphatic Filariasis in Japan 8.  
Most anthelmintic drugs used for human treatment were first developed for 
veterinary use 3,6. More importantly, parasites that infect humans are not included in 
drug development for veterinary parasites 6, even though these drugs have been 
repurposed for human treatment. There are several approved classes of drugs for 
humans, which include the benzimidazoles, the nicotinic acetylcholine receptor agonists 
and the macrocyclic lactones. Ivermectin, a drug in the class of macrocyclic lactones, is 
less effective against hookworms and whipworms, and is used to treat filarial nematode 
infections 6. In more developed parts of the world, the impact from parasitic worms is 
expressed as an increase in veterinary costs, especially in food production, where large 
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amounts of anthelmintic drugs are given to livestock 4. As a result, anthelmintic 
resistance has been detected in livestock, and must be acknowledged as a future 
problem in anthelmintics targeted for human use 3–5. 
The nematode Caenorhabditis elegans (C. elegans) has been the primary species 
used in the laboratory for the search for new anthelmintic compounds 3,9. C. elegans is a 
well-studied species of nematode that is free-living, meaning that it is not parasitic. C. 
elegans has two sexes, hermaphrodites and males 1,3,10. C. elegans is most easily 
cultured on the bacteria Escherichia coli (E. coli) in the laboratory 10. However, while 
C. elegans is a useful nematode for the study of animal development and behavior, C. 
elegans alone cannot represent the diversity of parasitic nematodes for anthelmintic 
drug development. For example, the sheep parasite Haemonchus contortus, and the 
parasite responsible for Lymphatic Filarisis, Brugia malayi, exist as males and females 
11. Therefore, while C. elegans may be more popular as a model organism in the 
laboratory, it is not clear whether nematodes that exist as males and females show 
different sex-dependent responses to anthelmintic compounds.  
The nematode Panagrellus redivivus (P. redivivus) can be traced back to 
Linneaus’ description of an organism in the genus Chaos and identified as Chaos 
redivivum 12. P. redivivus is also known as the beer mat nematode. The various names 
of P. redivivus reflect the locations of discovery of the worm. P. redivivus has been 
found in beer mats, insect frass, tree wound slime and wheat paste, but is always 
associated with yeast 12. The genus name Panagrellus was assigned by Goodey in 1945, 
and in 1984 P. silusiae was designated as a synonym for P. redivivus 12.  
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P. redivivus has been used as a comparative species relative to C. elegans in 
various studies 1,2,13. P. redivivus was the first free-living nematode to be sequenced 
outside of the Caenorhabditis genus 1. In the lab, P. redivivus can be cultured on a 
water-based mixture of oatmeal and yeast, or flour and yeast 14,15. Alternatively, P. 
redivivus can be maintained on E. coli and agar plates 1,2. On a wheat paste mixture P. 
redivivus worms can grow to a population of 500,000 within 20 days and survive 
without replenishing the mixture for 40 days 14. P. redivivus thrive at lower pH values, 
the population of worms declining with a decrease in acidity 14. Unlike C. elegans, P. 
redivivus is a gonochoristic species, with males and females1,15,16. Larvae hatch within 
the adult female and exit through the vulva 1,15.  
P. redivivus and C. elegans share many features. Compared to C. elegans, P. 
redivivus exhibits different locomotor behavior in response to food, but both species 
have similar staining patterns of dopaminergic and serotoninergic neurons2. Differences 
between nematode families can be evaluated most basically by placing individuals on 
an agar plate and observing their behavior 2,6,17. However, for the purposes of 
anthelmintic drug development and the search for new anthelmintic compounds, it is 
important to note that many of the drugs used today affect ion channels and 
neurotransmitter receptors18. Observation of nematode motility on agar plates does not 
give data sensitive enough to distinguish the mechanism of action on a particular 
species 19. A drug that affects nematode neurotransmitter receptors for example, 
ivermectin (IVM), can target multiple receptor subunits encoded by multiple genes in a 
species 20. In C. elegans alone there are at least 5 genes that encode different types of 
chloride channel subunits, and mutations in these subunits have conferred IVM 
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resistance to C. elegans 20. One advantage of drugs that target nematode 
neurotransmitter receptors or ion channels is the similarity of genes that encode for 
receptors between different nematode species 18.  
To identify a compound that affects ion channels or neurotransmitter receptors, a 
more sensitive measure of the effect of anthelmintic drugs is required. Observing the 
behavior of the nematode pharynx is more sensitive in assessing neurotransmitter 
receptor activity than a motility assay. The pharynx is a muscular throat structure in the 
nematode head that is used to draw food into the body of the worm 13,19,21. In C. elegans 
and similar nematodes, there are two types of pharyngeal behaviors: “ pumping” and 
“peristalsis” 21,22. Pumps refer to pharyngeal contractions that occur when the worm 
sucks in bacteria, and subsequently moves the bacteria to be chewed up in its grinder 
21.The neuromuscular signal of the pharyngeal muscle in nematodes can be monitored 
via the electropharyngeogram (EPG) method 13,19,21,22. In a manner similar to the 
electrocardiogram, an EPG recording measures the signal generated by the action of 
pharyngeal muscles and neurons 13,19,21. Pharyngeal peristalsis does not generate EPG 
currents 21. Therefore, the EPG method captures pumping modulated by 
neurotransmitters in all nematodes that produce this behavior. In EPG assays, the 
neuromodulator serotonin is used to stimulate pharyngeal pumping 13,19,21,22.The original 
EPG recording method 22, is not suited for large batches of recordings, because an 
experimenter must load individual worms into a pipette to begin recording. The 
microfluidic EPG chip method improves upon the conventional EPG recording method 
by automating the loading and recording of eight worms simultaneously 19. 
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As a nematode species with males and females, and with its ease in rearing, P. 
redivivus has the potential to be used as an alternative to parasitic nematode species for 
screening compounds with anthelmintic drug activity. To my knowledge, potential sex 
differences in the response to anthelmintic drugs have not been explored in P. redivivus. 
I decided to use the microfluidic EPG method to investigate potential sex-related 
differences in the response of P. redivivus to the anthelmintic drug IVM.  
Materials and Methods  
Panagrellus redivivus, strain Pr MT8872 were obtained from the 
Caenorhabditis Genetics Center (CGC; Minneapolis, MN). P. redivivus were 
maintained on an oatmeal and yeast mixture at room temperature. Twenty ml of water 
was added to approximately 9 g of Gerber Oatmeal Cereal single grain in a PI-750, 
29.57 ml (71/2 fl oz.) tumbler from Plastics Inc., Coon Rapids, Minnesota. Two portions 
of the oatmeal and yeast mixture were prepared at the same time. Approximately 0.7 g 
of yeast was added to each water and oatmeal mix, and P. redivivus were added. The 
food mixture was replaced weekly.  
A portion of oatmeal-yeast mix was placed on an agar plate and worms were 
picked into a glass well containing M9 buffer before each experiment23. Worms were 
first washed in the M9 solution to remove oatmeal particles then placed into glass wells 
containing a mixture of serotonin (5-hydroxytryptamine, 5HT) and M9 solution (see 
below). Males and females were identified via visual inspection according to Sternberg 
et. al. (1981) and Hechler (1970).   
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Microfluidics  
Chips were fabricated using the replica molding technique, and standard 
lithographic methods as adapted by Lockery et. al. (2012) from Xia and Whitesides 
(1998). In brief, a silicon wafer master was created with 1 layer of 70 µm SU-8 2050 
photoresist through a transparency mask of the 8-channel chip features. The wafer was 
developed via submersion in glycol monomethyl ether acetate (PGMEA). 
Chlorotrimethylsilane was applied after the development step to help release 
polydimethylsiloxane (PDMS) from the master. Chip masters were fabricated by K.L. 
Robinson.  
A layer of PDMS (Dow Corning Sylgard 184, Corning, NY) was poured into a 
master with the 8-channel chip design. To cure, the PDMS and master were baked at 
65˚C for 3 h. After curing, the PDMS was cut away from the master. Biopsy punches 
were used to complete the features of the chip: 1.5 mm for the ports and inlets, and 5 
mm for the reservoirs. After work on the features of the chip, the PDMS layer was 
bonded to a glass slide after 30 s exposure to oxidizing air plasma. The PDMS layer 
was placed on a glass slide, feature side down and baked at 65˚C for 1 h to complete the 
bonding process. After bonding, the capacity of each fluid reservoir was increased by 
inserting a 1.5 cm length of 5 mm glass tubing. 
Solution preparation 
The serotonin (5-hydroxytryptamine) solution was prepared with 0.1 M 
Serotonin creatinine sulfate monohydrate powder (Sigma H7752-5G, St Louis, MO) 
and diluted to a stock solution of 40 mM in M9 buffer. Serotonin solution is abbreviated 
as 5HT. M9 buffer was composed of 3 g KH2PO4, 6 g NaHPO4, 5g NaCl, 1 ml of 1M 
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MgSO4 in 1 liter of water according to Sulston et. al (1988). Serotonin dissolved in M9 
buffer is subsequently referred to as 5HT-M9. 40 mM aliquots of 1ml 5HT-M9 were 
stored at 20˚C.  
Before an experiment, 40 mM of 1 ml 5HT-M9 were mixed with 3 ml of M9 to 
give 4 ml of a 10 mM 5HT-M9 solution that was filtered with a 25 mm Acrodisc 
Syringe Filter (0.2 µm HT Tuffryn Membrane Pall 4192; Ann Arbor, MI). Adult P. 
redivivus were incubated for 45 minutes in the 10mM 5HT-M9 solution. Previous 
experiments determined that a 45 minute pre-exposure to 10 mM 5HT-M9 was required 
to ensure that P. redivivus worms were pumping at maximum frequency (K.L. 
Robinson, unpublished data).  
Two aliquots of 1 ml 5HT-M9 were mixed then filtered with 6 ml of M9 to 
create the 10 mM 5HT-M9 control solution. One aliquot of 1 ml 5HT-M9 was mixed 
with 2.6 ml of M9 and 0.4 ml of 0.05% fast green dye to create a 10 mM 5HT 
experimental dye solution. The IVM (Sigma I8898, St. Louis, MO) solution was stored 
as a 5 mM stock solution in 1 ml aliquots at -20˚C. IVM was dissolved in 0.06% 
Dimethyl Sulfoxide (DMSO). After the experimental solution was filtered, 1.8 µl of 
DMSO or IVM was added to give a 3 ml drug solution of 0.06% DMSO or 3 µM IVM. 
Worm loading 
After 45 min pre-exposure to 10 mM 5HT-M9, adult P. redivivus were loaded 
into an 8 channel EPG chip. Adult male and female P. redivivus were determined by 
visual observation of gonadal structures as described by Hechler (1970). A 3 cc syringe 
of freshly prepared 10 mM 5HT-M9 was connected to the perfusion inlet of the chip 
and the chip was filled. Pre-exposed adult P. redivivus were picked with platinum wire 
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into the inlet port and the worms allowed to settle to the bottom of the inlet port. After 
the worms settled, the syringe filled with control solution was reattached and used to 
gently push the worms into the channels of the chip. Waste reservoirs were inserted into 
the worm and drug vents of the chip. 
EPG recording  
After loading the chip, the syringe filled with control solution was left attached, 
and the chip placed on the rig. Without removing the syringe, 0.5 inch passivated 1 
gauge steel tube electrodes (0.058 inch OD, 0.0475 inch ID, New England Small Tube, 
Litchfield, NH) were inserted into the electrode ports. EPGs were recorded via AC 
differential amplifiers (A-M Systems model 1700, Carlsborg, WA). Solutions were 
perfused through the chip at 6 µl / min. The control solution was perfused through the 
chip for 30 min then a switch was made to the experimental solution of 3 µM IVM or 
0.06 % DMSO. The experimental solution was perfused through the chip for 1 hour.  
Recordings were made at a voltage gain of 1000x with a bandwidth of 500 to 1 
Hz, and a notch filter at 60 Hz. Data were recorded with an analog to digital converter 
[Micro1401-3, Cambridge Electronic Design (CED), Cambridge, UK]. Readouts were 
stored using Spike2 software (version 7.06a, CED). Data were down sampled to 500 
Hz. A keystroke channel was used to keep track of when the dyed experimental solution 
reached the worms. Orientation and sex of each worm was recorded after the 
experiment under an upright scope.   
  
 
 
10  
Analysis  
After experiments, recordings were viewed using Spike2. Noisy or empty 
channels were excluded before saving the data as text files. Text files were imported 
into the IGOR Pro software environment (Wavemetrics, Lake Oswego, OR) for analysis 
using a custom algorithm 24 that identified each pharyngeal pump in the data. To 
compare the time required for the drug solution to take effect, the algorithm computed a 
t1/2 value for each worm. The algorithm defined t1/2 as the time during the 60 minute 
observation period following addition of the drug at which half of the pumps during the 
60 minutes had occurred. A frequency criterion, such as the time required for the pump 
frequency to fall to 50% of its baseline rate, was not used. Because pumping was often 
interrupted by brief pauses, causing the worm’s pump frequency to be highly variable in 
time, a simple frequency criterion was too noisy. The t1/2 was less impacted by 
interruptions in pump activity. A t1/2 value was computed for each worm and the Mann-
Whitney U-test 25 was used to compare t1/2 values between groups of worms.  
Results 
Figure 1 shows the EPG chip with 8 electrodes attached; the common reference 
electrode was not inserted into the inlet port (top) in this view. Red dye was injected 
into the inlet port to highlight the branching channels within the chip. The electrodes 
were inserted into their respective ports at the bottom. Waste reservoirs were located 
beyond the electrodes at the bottom of the chip. 
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Figure 1: An EPG chip 
 This chip has been filled with red dye to highlight the 
micro-channels. 
Photo credit: Derek Robinson 
 
Figure 2 shows a schematic of the chip and the location of a worm in the worm 
trap. The arrows in the inset show the flow of solution through the chip. The transparent 
quality of the EPG chip allowed for clear observation of a worm in a channel. The best 
recordings were generated from worms firmly ensconced within the trap. Solutions 
could also be observed, and I used dye in my experimental solutions to create a visual 
marker of exactly when worms were exposed to 3 µM IVM or 0.06% DMSO. 
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Figure 2. EPG chip design. 
Top: PDMS fabrication design. Bottom: expanded view shows the recording module 
portion of one of the eight channels. Modified from Lockery et al. (2012). 
 
Figure 3 shows representative EPG recordings from P. redivivus individuals 
under different experimental conditions. Each trace is an excerpt of the recording from 
an individual worm in four different experiments. The first two recordings (Fig. 3A, 3B) 
show a steady pump frequency in females and males that were switched from control 
solution to 0.06% DMSO. The recordings have been compressed in time so the EPG 
waveforms appear as a thick line. Comparison of pump frequency between males and 
females in 5HT-M9 showed no significant difference during the baseline period. Males 
had a mean pump frequency of 1.80 Hz (n=46, S.E.M ± 0.168 Hz), females had a mean 
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pump frequency of 2.01 Hz (n=46, S.E.M ± 0.158 Hz; U statistic 1002, p = 0.66). In 
Figures 3C and 3D, pumping in female and male worms became less frequent over time 
after switching the perfusion to 3 µM IVM.  
A.  
 
B.  
 
C. 
 
D.  
 
 
Figure 3. Sample EPG Traces 
Traces show portions of the baseline (control) and experimental periods of EPG 
recordings from 4 different worms. The arrows mark the time of the switch of 
solution from control to experimental solution.  
A. Female exposed to 0.06% DMSO. B. Male exposed to 0.06% DMSO. C. Female 
exposed to 3 µM IVM. D. Male exposed to 3 µM IVM. 
5min 
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Figure 4 shows data from males exposed to IVM or DMSO. Early in my work 
with P. redivivus I noticed that adult males exposed to 5HT-M9 exhibited a tail curling 
behavior (see Discussion). Males curled the posterior third of their bodies into a tight 
spiral, and maintained this shape even when loaded into the EPG chip. Females did not 
exhibit this curling behavior. In Fig. 4A, time is plotted on the x-axis and pump 
frequency is plotted on the y-axis. These data were normalized to the pump frequency 
of the last 2 minutes of the control period. The negative time period in part A 
corresponds to the 5HT-M9 solution. Time 0 marks the time when the solution switch 
occurred. Males exposed to 0.06% showed a steady pump frequency throughout. In 
contrast, males exposed to 3 µM IVM show a steady decrease in pump frequency.  
In Fig. 4B, a pump frequency integration curve summarizes the data from Fig. 
4A. The y-axis shows the mean fraction of total pumps taken by each worm over the 
course of the experimental period. The x-axis shows time starting at 0 min, the 
beginning of the experimental period. Males exposed to 0.06% DMSO achieved 50% of 
their total pumps at ~29 minutes (mean = 29.43 minutes, S.E.M ± 0.8215). Males 
exposed to 3 µM achieved 50% of the total pumps at 21 minutes (mean = 21.69 
minutes, S.E.M ±0.836). U statistic 48, p = 3.93 x 10-8. Thus, exposure to 3 µM IVM 
caused a statistically significant reduction in pumping frequency compared to DMSO 
controls in adult male P. redivivus.  
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A.  
B.  
Figure 4. Ivermectin vs. DMSO: Mean pump frequency and integration curve data 
from males 
A. The negative time period (-15 to 0 min) corresponded to the baseline recording 
period, while the worms are exposed to 5HT-M9. The first 15 min have been cut off. 
Blue line shows males exposed to 0.06% DMSO (n=26). Teal line shows males 
exposed to 3 µM IVM (n=20). The grey bar masks the electrical artifact produced by 
switching from the control to the experimental solution. Shading represents ± 1 
S.E.M. 
B. Male pump rate integration curves. Color scheme as in A. T1/2 is apparent from the 
dotted line at 0.5 on the y-axis. Comparison of t 1/2 by the Mann-Whitney U-test 
showed a significant difference between the IVM and DMSO groups, P< 0.0001 
(3.93x10-8). The linear DMSO males curve corresponds to a steady pump frequency 
during the experimental period. Shading represents ± 1 S.E.M. 
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A.  
B.  
Figure 5. Ivermectin vs DMSO: Mean pump frequency and integration curve data 
from females 
A. The negative time period (-15 to 0 min) corresponded to the baseline recording 
period, while the worms were exposed to 5HT- M9. The first 15 min have been cut 
off. Pink line shows females exposed to 0.06% DMSO (n=26). Purple shows females 
exposed to 3 µM IVM (n = 20). Shading represents ± one S.E.M. The grey bar masks 
the electrical artifact produced by switching from the control to the experimental 
solution. 
B. Female pump rate integration curves. Color scheme as in A. T1/2 is apparent from 
the dotted line at 0.5 on the y-axis. Comparison of t 1/2 by the Mann-Whitney U-test 
showed a significant difference between the IVM and DMSO groups, P< 0.0001 
(6.41x10-7). The linear DMSO females curve corresponds to a steady pump rate 
during the experimental period. Shading represents ± one S.E.M. 
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In Figure 5, females exposed to 3 µM IVM are compared to females exposed to 
0.06% DMSO. As in Figure 4, the y-axis displays normalized pump frequency and the 
x-axis includes the last 15 minutes of the control period. Time 0 marks the time of the 
solution switch. Females exposed to 0.06% DMSO showed a steady pump frequency 
whereas females exposed to 3 µM show a decrease in pump frequency during the 
experimental period.  
In Figure 5B, a pump frequency integration curve summarizes the data from 
Figure 5A. The y-axis shows the average fraction of total pumps taken by each worm 
over the course of the experimental period. The x-axis shows time starting at 0 min, at 
the beginning of the experimental period. Females exposed to 0.06% DMSO achieved 
50% of their total pumps at 29 minutes (mean = 28.17 minutes, S.E.M. ± 0.842). 
Females exposed to 3 µM IVM achieved 50% of their total pumps at 20 minutes (mean 
= 20.17 minutes, S.E.M ±0.842). U statistic 467, p = 6.41 x 10-7. Thus, exposure to 3 
µM IVM caused a statistically significant reduction in pumping compared to DMSO 
controls in adult female P. redivivus. 
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A.  
 
B.  
Figure 6. DMSO mean pump frequency and integration curve data, males and females. 
 A. The negative time period (-15 to 0 minutes) corresponded to the baseline recording 
period, while the worms are exposed to 5HT-M9. The first 15 minutes have been cut off. Blue 
line shows males exposed to 0.06% DMSO (n=26). Pink line shows females exposed to 
0.06% DMSO (n=26). Shading represents ± one S.E.M. The grey bar masks the electrical 
artifact produced by switching from the control to the experimental solution. 
B. DMSO Male and female pump rate integration curves. T1/2 is apparent from the dotted line 
at 0.5 on the y-axis. Comparison of t 1/2 by the Mann-Whitney U-test showed no significant 
difference between males and females, P= 0.365. The linear DMSO males curve corresponds 
to a steady pump rate during the experimental period. Shading represents ± one S.E.M. 
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Figure 6 compares males exposed to 0.06% DMSO to females exposed to 0.06% 
DMSO. As in Figures 4A and 5A, Figure 6A shows that males and female exposed to 
0.06% DMSO displayed a steady pump frequency. Males had a normalized pump 
frequency slightly above baseline compared to females.  
 In Figure 6B, the pump frequency integration curve summarizes the data from 
Fig. 6A. Males and female exposed to 0.06% DMSO had a steady pump frequency. 
Males achieved 50% of total pumps at 29 minutes (mean =29.43 minutes, S.E.M ± 
0.821). Females achieved 50% of total pumps at 28 minutes (mean = 28.17minutes, 
S.E.M.± 0.842). These values did not differ significantly (U statistic = 388, p = 0.365).            
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A.  
B.  
Figure 7. Ivermectin: mean pump frequency and integration curve data males, 
females. 
A. The negative time period (-15 to 0 minutes) corresponded to the baseline 
recording period, while the worms were exposed to 5HT-M9. The first 15 minutes 
have been cut off. Teal line shows males exposed to 3 µM IVM (n=20). Purple line 
shows females exposed to 3 µM IVM (n = 20). Shading represents ± one S.E.M. The 
grey bar masks the electrical artifact produced by switching from the control to the 
experimental solution. 
B. Ivermectin male and female pump rate integration curves. T1/2 is apparent from 
the dotted line at 0.5 on the y-axis. Comparison of t 1/2 by the Mann-Whitney U-test 
showed, no significant difference between males and females, P = 0.409. The linear 
DMSO males curve corresponds to a steady pump rate during the experimental 
period. Shading represents ± one S.E.M. 
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In Figure 7, females exposed to 3 µM IVM were compared to males exposed to 
3 µM. In Figure 7A, time is plotted on the x-axis, and pump frequency is plotted on the 
y-axis. These data have been normalized. The negative time period in panel A 
corresponds to the last 15 minutes of the 30 minute control period when the worms 
were exposed to 5HT-M9. Time 0 marks the time when the solution switch occurred. 
Both sexes displayed a decrease in pump frequency during the 60 min experimental 
period.  
In Figure 7B, a pump frequency integration curve restates the data from Figure 
7A. The y-axis shows fraction of total pumps. The x-axis shows time, starting at 0 
minutes, the beginning of the experimental period. Females achieved 50% of total 
pumps at 20 minutes (mean = 20.10 minutes, S.E.M. ± 1.22). Males achieved 50% of 
total pumps at 21 minutes (mean = 21.69, S.E.M. ± 0.836). U statistic = 169, p-value 
0.409. Both males and females reached 50% of total pumps after 20 minutes, with both 
sexes taking a decreasing fraction of their total pumps for the next 40 minutes. 
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Discussion 
In this thesis I examined sex-related differences in pharyngeal pump frequencies 
in response to IVM using EPG chips. My hypothesis was that male and female P. 
redivivus have different sensitivity to anthelmintic drugs. To identify potential 
differences in males and females, I compared the electrical signals of male and female 
P. redivivus generated by the pumping of the pharynx during exposure to 3 µM IVM.  
With each EPG experiment, I included a pre-exposure period where males and 
females were exposed to a 5HT-M9 solution for 45 mins before being placed in a chip.  
After the 45 minute pre-exposure period, the worms were loaded into the chip, and the 
first 30 minutes on the rig were a control period where the worms were exposed to 
5HT-M9. The 45 min pre-exposure was necessary to elevate the baseline pump 
frequency, and maintain pharyngeal pumping at a steady state. In the results section of 
this thesis, I cut off the first 15 minutes of this control period. This control period was 
necessary to confirm that the worms were pumping at a steady frequency inside the 
chip. After the 30 minute control period, worms were exposed to DMSO or IVM for 1 
hour.  
 During the pre-exposure period, I observed that males exclusively displayed a 
tail-curling/paralysis behavior. The male tail-curling appeared to be irreversible; with 
males displaying a tight curl even after the experiment was finished. In. C. elegans, tail 
curling is the physical mechanism by which C. elegans males search for the 
hermaphrodite vulva while wrapped around their prospective mate 17. Male-specific tail 
curling has been observed in C. elegans, at 5HT concentrations of 10-20 mM, males are 
unable to uncurl their tails 17.  
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It has been observed that the P. redivivus pharynx produces a standard electrical 
signal that corresponds to the excitation, resting and repolarization phases during 
exposure to serotonin13. Serotonin immunoreactivity staining experiments on C. elegans 
and P. redivivus show strong staining of serotonergic neurosecretory motor neurons 
located in the pharynx 2. The advantage of using the EPG method in my experiments is 
that it gives a readout of what is occurring as a worm is exposed to a drug or compound 
that affects the nervous or muscular systems. Ivermectin activates glutamate-gated 
chloride channels in nematodes, resulting in virtually irreversible paralysis of the 
pharynx and body-wall muscle 20. My experiments confirm that P. redivivus displays a 
similar decrease in pump frequency over time as observed in C. elegans exposed to 3 
µM IVM 19. The effect of 3 µM IVM on male and female P. redivivus was not 
significantly different.  
In conclusion, there is no sex difference in pharyngeal pumping between males 
and females when exposed to 10 mM 5HT or 3 µM IVM. The similarity of P. redivivus 
pharyngeal response to the C. elegans pharynx is a positive mark in favor of P. 
redivivus as an alternative to C. elegans as an experimental model nematode in the 
search for new anthelmintics. I observed a tail-curling response to 5HT that suggests 
new avenues for research with P. redivivus. Male adult P. redivivus displayed 
effectively permanent tail-curling when exposed to 10mM 5HT a response not seen in 
females. Therefore, P. redivivus does display sexually distinct behavior in response to 
the neuromodulator 5HT, but not to the anthelmintic IVM. Similar sex-linked mating 
behavior has been observed in C. elegans 26. 
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In C. elegans, neuronal circuits involved in mating and locomotion differ 
according to the sex of the individual 26. My observation of male-specific tail curling 
suggests that P. redivivus may also have sexually distinct neuronal circuits. In the 
search for new anthelmintic drugs, sex associated genes, as well as neurotransmitter 
receptors may be targets for new anthelmintics. Li (2016) preformed the first genome-
wide analysis of sex associated gene expression in Brugia malayi, one of the nematodes 
responsible for Lymphatic Filariasis. In B. malayi, metabolic, energy and cell-motility 
processes were more expressed in males, while cell-cycle, transcription and translation 
related pathways were more expressed in females 26. Li (2016) also found sex 
associated homologues in C. elegans, genes that are differentially expressed according 
to sex.  
Ivermectin’s discovery was something of a fluke. In the 1970s, IVM’s 
anthelmintic activity may have remained unknown without Dr. Satoshi Ōmura, who 
focused on investigating naturally occurring compounds and their potential for drug 
development 27,28. Today, the Weeks lab, in collaboration with the Gabon-Oregon 
center, aims to make the discovery of new, naturally-occurring anthelmintic compounds 
less dependent on chance 29. With an easy-to-raise nematode like P. redivivus, and the 
ability to use males and females, researchers studying the anthelmintic properties of 
plant extracts may have a powerful tool for identifying new naturally occurring 
anthelmintic compounds. With the EPG method, the mode-of-action of new 
anthelmintic compounds can be explored in different species of nematodes. More 
research needs to be done with P. redivivus, however, as IVM represents only one class 
of anthelmintic compound. In addition, P. redivivus, as a gonochoristic species, may 
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also be a useful tool in the search for compounds that affect the two sexes differently in 
nematodes. If I were to continue to investigate the effects of anthelmintic drugs on P. 
redivivus, I would investigate the effect of the major classes of anthelmintic drugs on P. 
redivivus males and females using the EPG chip method.  
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Glossary 
Caenorhabditis elegans 
-A non-parasitic nematode. The first multicellular organism to undergo complete 
genome sequencing. 
 
Anthelmintic 
-A type of anti-parasite drug that acts on nematodes and other parasitic worms.  
 
Panagrellus redivivus 
-A non-parasitic nematode that can be grown on a flour or oatmeal paste. 
 
Electropharyngeograms (EPGs) 
-A technique that records the signal from the action of the nematode pharynx 
(throat muscle). 
 
Gonochoristic 
-Also known as unisexualism; the state of only having one of at least two 
distinct sexes in an organism. 
 
Ivermectin (IVM) 
-An anthelmintic drug in the class of macrocyclic lactones. Causes 
hyperpolarization of pharynx and body wall muscle in nematodes, leading to 
paralysis.  
 
DMSO 
-Dimethyl Sulfoxide. A colorless liquid solvent. 
 
Dopaminergic 
-Related to dopamine. Dopamine is a neurotransmitter. 
 
Serotonergic 
-Related to serotonin. Serotonin is a neuromodulator. 
 
Serotonin 
-A neuromodulator and a chemical messenger used to transmit signals in the 
nervous system. Also called 5-hydroxytryptamine (5HT) 
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Experimental Protocol for EPGs: P. redivivus Step 1: Pre-expose P. redivivus to 5HT -Remove a 40 mM aliquot of 5HT-M9 from the -20˚C freezer. -Mix with 3 ml of 1xM9 to make a 10 mM solution that is a total of 4 ml. -Filter with a 10 cc syringe and pipet the amount into an empty glass well.  -Pick adult P. redivivus into the well; pre-expose adult P. redivivus to the 10 mM 5HT solution for at least 45 min before running the experiment.  Step 2: Mix up reagents 40 mM aliquots of 5HT are in the -20˚C freezer -Remove 3 aliquots of 5HT from the -20˚C freezer. - For the 5HT Control solution, add 6 ml of M9 to 2 ml of 40 mM 5HT in order to achieve a 10 mM solution of 5HT-M9. -For the Experimental (drug) solution, take 1 ml of 40 mM 5HT and add 2.6 ml M9 and 400 µl (0.4 ml) 0.05% fast green dye to achieve a 10 mM solution (if you are using a large volume of drug subtract from M9 before mixing solution). - Filter each solution into small petri dishes. The filter will hold some of the 
solution. This is not a problem for the Control solution as it is already at the correct concentration.  - For the Experimental (drug) solution only take 3 mls from the filtered volume in the petri dish.  -Calculate the amount of drug needed remove this amount from the filtered 
solution, then add drug. Subtracting the added amount will ensure molarity.  -Fill two 3 cc syringes with Control (baseline) solution- one for the rig, one for the loading syringe.  -Fill one 3 cc syringe with Experimental (drug) solution. Step 3: Set up Rig 
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- Use the leur lock to connect syringes (Control soln. and Experimental soln.) 
with tubing, place snugly into syringe pump.  - Turn syringe pump on.  - Prime tubing by allowing the pump to perfuse at 6 ml/min into waste container. This will fill tubing and prevent air bubbles from occurring in the tubing.  - Once the solution has reached the electrode pump, speed should be turned down to 6 µl/min.  - Turn on amplifiers, CED, A/D board, computer and Spike2 software.   Step 4: Load Worms  -Take prepared 3 cc syringe with filter and fill syringe with Control solution-there should be plenty for rig syringe and loading syringe.  -Preload the chip by connecting the syringe via Leur lock and tubing and filling the chip until solution appears in the electrode ports.  - Select adults from the pre-exposure well and place them in the inlet port of the chip.  - Connect syringe and gently propel worms into individual channels.  - Keep syringe connected and insert glass reservoirs. -Check worm placement and apply pressure to syringe if necessary for correct worm placement.  - Carry chip to rig and connect to already running perfusion electrode. Allow the perfusion electrode to run solution through the chip for about 1 min. This will allow the electrode ports to fill and prevent air bubbles from entering the chip when electrodes are inserted.  - Insert 8 individual recording electrodes.  -Check signals and adjust as needed-may require removal of air bubbles or re-insertion of recording electrodes to obtain a good signal.  Step 5: Recording  - Turn on Spike2 program. - Select File-> New data document. - Press start. - Collect baseline recording for 30 min. - Switch to drug solution. 
o Press “A” three times  
 “A” when pump is turned off. 
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 “A” switch to drug and restart pump. 
 “A” observe the chip as drug is pumped, press when drug hits worm. - Continue to record for 1 hr. - Stop experiment after 1 hr of exposure to Experimental solution and save the file.   
Step 6: Clean-up and Notation  - Turn off amplifiers: unplug CED, A/D board, power supply, syringe pump. - Clean rig: rinse electrodes with de-ionized water in a petri dish, rinse tubing 
by attaching DI water, EtOH and air can to tubing, rinse reservoirs with de-
ionized water and dry on bench.  - Look at the chip under the upright scope. - Record orientation and sex. - Discard chip in glass waste.     
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